Weekly diabetes drug provides similar benefits to daily version
January 17, 2017
A weekly dipeptidyl peptidase-4 (DPP-4) inhibitor was just as effective at controlling type 2 diabetic patients' blood sugar as a daily DPP-4 inhibitor in a recent randomized clinical trial.
Read more
Reading level: College
EurekAlert!, the online, global news service operated by AAAS, the science society
Explore Our Science Videos
How Far Can a Sneeze Go?
Change the Reaction Rate of a Foaming Reaction
Delayed Release Pill Challenge